90% of Adults with Chronic Hepatitis Delta Who Cleared Virus on Bulevirtide Stayed Clear Nearly 2 Years After Stopping Treatment Gilead Sciences, Inc. (Nasdaq: GILD) today announced final results from the Phase 3 MYR301 study showing that nearly 90% of…
Global Health Inequities Slashing Lifespans by Decades, WHO Warns A new report by the World Health Organization (WHO) reveals that the root causes of poor health often lie outside the healthcare system — including inadequate housing, limited education, and lack…
WHO Highlights the Importance of Hand Hygiene Over Gloves on World Hand Hygiene Day Hand hygiene remains one of the most effective, affordable, and universal tools in preventing the spread of infections and ensuring high-quality, safe medical care worldwide. While…
73% of healthcare professionals (HCPs) report a disconnect between the availability of cutting-edge treatments and their effective implementation in clinical practice, while 3 in 4 oncologists say the rapid pace of new treatment development feels overwhelming. These insights reinforce Johnson…
BOTOX® Cosmetic Expands Commitment to Female Empowerment with The Confidence Project for Women Entrepreneurs In a bold move to champion female entrepreneurship and narrow the persistent confidence gap between men and women in business, Allergan Aesthetics, an AbbVie company (NYSE:…
Eli Lilly Reports Strong Q1 2025 Financial Results, Driven by Surging Demand for Mounjaro and Zepbound, While Advancing Pipeline Innovations Eli Lilly and Company (NYSE: LLY) has delivered a robust start to 2025, reporting a 45% year-over-year increase in revenue…
Crown Bioscience and NEXT Oncology Expand Strategic Partnership In a significant development that reinforces their shared vision for transforming cancer research and drug development, Crown Bioscience, a global contract research organization (CRO) under the umbrella of JSR Life Sciences and…
PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity PCI Pharma Services, a globally recognized contract development and manufacturing organization (CDMO) specializing in the development and commercialization of innovative biopharmaceutical therapies, has officially…
Verily Wins Michael J. Fox Foundation Grant to Build Major Parkinson’s Molecular Dataset In a significant development for neurodegenerative disease research, Verily, the Alphabet-owned precision health technology company, announced today that it has received a $14.7 million research grant from…
FUJIFILM Cellular Dynamics Names Delara Motlagh as Chief Operating Officer In a strategic move to enhance its operational leadership and accelerate the growth of its cutting-edge platforms in induced pluripotent stem cells (iPSCs) and cell therapy, FUJIFILM Cellular Dynamics, Inc.,…
Creyon Bio and Eli Lilly Forge Partnership to Develop RNA-Targeted Oligonucleotide Therapies Creyon Bio, Inc., a leader in innovative RNA-targeted therapies, has announced a transformative global licensing and multi-target research collaboration with Eli Lilly and Company, one of the world’s…
Qualthera Health Launches R&D Subsidiary for Drug Repurposing and Novel Delivery Qualthera Pharmaceuticals Ltd. Co. aims to reshape the future of therapeutics through a patient-driven, data-informed approach to repurposing proven compounds and revolutionizing drug delivery systems. Qualthera Health Corporation, a…